Background: Glycopeptides such as vancomycin are frequently the choice of antibiotics for the treatment of infections caused by methicillin resistant Staphylococcus aureus (MRSA). For the last 7 years incidence of vancomycin intermediate S. aureus and vancomycin resistant S. aureus (VISA and VRSA respectively) has been increasing in various parts of the world. Objective: The present study was carried out to find out the presence of VISA and VRSA among isolated MRSA strains. Methodology: This cross sectional study was carried out in the Department of Microbiology in Dhaka medical college during period of January 2010 to December 2011. All S. aureus isolates were screened to detect methicillin resistance and then all MRSA isolates were subjected for MIC testing against vancomycin and oxacillin by agar dilution method, disc diffusion testing and PCR for mecA and pvl genes detection. Result: A total 112 S. aureus were isolated from 500 nasal swab sample collected from adult patients who were admitted in various departments and wards in Dhaka Medical College Hospital. Among 38 MRSA strains out of 112 Staph aureus isolates 3(7.89%) strains were resistance to vancomycin of which 2(5.26%) strains had MIC > 256 g/mL and one strain had MIC 256g/mL. All vancomycin resistance strains had MIC of oxacillin > 256 g/mL. All isolates possess mec-A gene. Conclusion: The present study reveals that emergence of VRSA upon admission at a tertiary care of hospital in Bangladesh. Continuous efforts should be made to prevent the spread and the emergence of VRSA by early detection of the resistant strains and using the proper infection control measures in the hospital setting.
Introduction
Staphylococcus aureus (Staph aureus) is one of the most common causes of both endemic and epidemic infections acquired in hospitals, which results in substantial morbidity and mortality 1 . Colonization with Staph aureus has been identified as an important risk factor for the development of Staph aureus infections in both community and hospital settings [2] [3] .
Multidrug-resistant strains of Staphylococci have been reported with increasing frequency worldwide, including isolates that are resistant to methicillin, lincosamides, macrolides, aminoglycosides, fluoroquinolones, or combinations of these antibiotics 4 . Recommended treatments for multidrug resistant MRSA are glycopeptides, particularly vancomycin 5 .
In the 1980s, due to the widespread occurrence of methicillin-resistant Staphylococcus aureus (MRSA), empiric therapy for Staphylococcal infections particularly nosocomial sepsis was changed to vancomycin in many health-care institutions. Vancomycin use in many countries also increased during this period because of the growing numbers of infections with Clostridium difficile and coagulase-negative Staphylococci in health-care facilities [6] [7] . The use of the glycopeptides antibiotic, vancomycin is increasing day by day 8 . As a consequence, selective pressure is established that eventually lead to the emergence of strains of Staph aureus with decrease susceptibility to vancomycin and other glycopeptides 9 . Staph aureus strains whose minimum inhibitory concentration (MICs) of vancomycin are 4 to 8 μg/mL are classified as vancomycin-intermediate (VISA) and the strains whose vancomycin MICs are ≥16 μg/mL are classified as vancomycin-resistant 10 . Resistance to vancomycin seems to develop from pre-existing strains of MRSA in the presence of vancomycin [11] [12] . VRSA strains are characterized by expression of vanA gene residing on Tn1546-like element which was acquired from an Enterococcus species 9, 13 . Therefore, this resistance is potentially transferable to susceptible strains or other organisms 9 . and Belgium 20 has confirmed that emergence of these strains is a global issue.
In Bangladesh, the frequency of MRSA is alarming may be due to indiscriminate and incomplete uses of antibiotics [21] [22] 25 . In Bangladesh, though MRSA infection is more frequent, but there is no adequate information on VRSA and VISA strains and their resistance pattern. Therefore the present study was carried out to find out any VRSA and VISA among isolated MRSA strains.
Methodology
This cross-sectional study was carried out in the Department of Microbiology in Dhaka Medical college during the period of January 2010 to December 2011 for a duration of two(02) years. Five hundred adult patients were screened within 24 hours of their admission in different wards in Dhaka Medical college Hospital by taking nasal swab from both anterior nares and were analyzed. Data regarded by age, sex, previous h/o hospitalization ( within past 12 month) and their co-morbid conditions such as DM, COPD, CVD, CKD were collected from hospital records or directly from patients using predesigned data collection form. Nasal swab samples were plated on blood agar media and incubated at 37 0 c. Isolates were identified as Staph aureus by colony morphology, Gram staining and standard biochemical tests like catalase, coagulase and mannitol fermentation test 26 . Staph aureus isolates were screened for methicillin resistance by disc diffusion method using oxacillin (1µg) and cefoxitin (30µg) disc and by determination of minimum inhibitory concentration (MIC) of oxacillin by agar dilution method per recommendation of CLSI method 10 . The discrepancies of the result were confirmed by PCR assay which is gold standard method for detection of mecA gene by using specific primers 27, 28 . All MRSA isolates were tested for susceptibility against ceftriaxone (30µg), ciprofloxacin (5µg), doxycycline (30µg), erythromycin (15µg), gentamycin (10µg), rifampicin (5μg), vancomycin (30µg), fusidic acid (10µg) and linezolid (30µg) by disc diffusion method as recommended by CLSI 10 . The discs from each batch were standardized by testing against reference stain of Staph aureus ATCC-25923. VRSA were detected by disc diffusion method and by determination of MIC of vancomycin by agar dilution method. If inhibition zone diameter around vancomycin (30µg) disc was ≤14 mm and MIC of vancomycin was ≥ 16 µg/ml than it was considered as VRSA. MIC of vancomycin was 4 to 8 µg/ml, was considered as Bangladesh J Infect Dis 13 June 2016│ Volume 3│Number 1 VISA. MIC of vancomycin <4µg/ml were considered as VSSA 10 . Minimal inhibitory concentration (MIC) of oxacillin, vancomycin were determined by agar dilution method using CLSI guidelines 10 . Briefly, gradient plates of MuellerHinton agar were prepared with oxacillin (0.5-256 μg/ml) (with 2% NaCl), vancomycin (0.5-256 μg/ml). By direct colony suspension method 0.5 McFarland equivalent inoculums were prepared in normal saline from culture plate. The suspension was further diluted to achieve desired inoculum concentration of 10 5 CFU/ml. All strains were spotted onto gradient plates. Plates were incubated overnight at 37°C for any visible growth. Readings were taken according to CLSI guidelines 10 . S. aureus ATCC 25923 were used as vancomycin susceptible controls. (Table 3) . Antimicrobial resistance pattern of VRSA was varied. Out of 3 VRSA isolates two (66.66%) strains were resistant to rifampicin and fusidic acid, and one (33.34%) VRSA strain was also resistant to linezolid but sensitive to doxycycline and gentamycin. All (100%) were resistant to erythromycin (Table 4) . Antimicrobial susceptibility pattern and patients profile among the VRSA cases were recorded. Among 3 VRSA cases, 2 VRSA colonized male patients were above 70 years of age and one female was 35 years of age. All had history of previous hospitalization and all had multiple co-morbidities (Table 5 ). 
Results

Isolation rate of
Discussion
Infections caused by methicillin-resistant S. aureus have been associated with high morbidity and mortality rates. In Bangladesh, the frequency of MRSA is alarming may be due to indiscriminate and incomplete uses of antibiotics [21] [22] . In Bangladesh, the rate of MRSA infection ranges from 32% to 63% in different hospitals 29 . The present study showed 33.9% out of 112 Staphylococcus aureus were MRSA. Vancomycin is the main antimicrobial agent available to treat serious infections with MRSA but unfortunately, decrease in vancomycin susceptibility of S. aureus and isolation of vancomycin-intermediate and resistant S. aureus have recently been reported from many countries 29 . In the present study, 3(7.89%) isolates were resistant to vancomycin among 38 MRSA strains. MIC of vancomycin was determined by agar dilution method. In this study, of the three VRSA strains, 2 VRSA strains had MIC > 256 g/ml and one strain had MIC 256g/ml. In this study VRSA isolates were also methicillin-resistant had MIC of oxacillin >256µg/ml and contained mec-A gene The first strain of S. aureus with reduced susceptibility to vancomycin was found in 1997 named MU50 showed MIC of 8g/ml 14 . Vancomycin resistance Staphylococcus aureus (VRSA) strain was first reported in United States in 2002 which had MIC 32 g/ml 8 . Saderi et al 12 from Iran reported that out of 139 Staphylococcus aureus strains 5 VRSA isolates had MIC >128 g/mL. That study also reported that one VRSA strain had MIC more than 256 g/mL. In the present study, out of 3 VRSA-patients, 2 were above 70 years old male and one was 36 years old female. All the three patients were associated with multiple comorbidities, had history of previous hospital admission and received multiple antibiotics. The only female patient had diabetes mellitus and had wound infection. Misuse of antimicrobial agents and the spread of multidrug-resistant strains are facilitated by poor hygiene and are related with multidrug resistance strains of MRSA. A study in Bangladesh reported that widespread and suboptimal use of antimicrobial agents was an important factor for high prevalence of resistant strains 22 .
In Bangladesh, a study conducted at Dhaka Medical College reported that all MRSA isolates were susceptible to vancomycin 24 . In comparison with previous study it reflected that the sensitivity of vancomycin was reduced over the past years. However, it might be possible that irrational and over use of antibiotic is increasing day by day which may contribute to the development of multidrug resistance. Another possible mechanism of VRSA is presence of van-A gene which was not studied in this study. Nancye et al 13 and Tenover et al 9 reported that vancomycin-resistant enterococci containing van-A were isolated from patients with MRSA strain. The van-A gene is usually found in enterococci which confers high-level vancomycin resistance (MICs=512-1024μg/ml) and van-A determinant is transferred via plasmids from enterococci to a resident MRSA strain, resulting in the VRSA 30 . In this study VRSA isolates were also methicillin-resistant and contained mec-A gene. If prompt measures are not taken to prevent indiscriminate use of antibiotics and prevent hospital spread of VRSA then it may be a serious health problem in Bangladesh.
In the present study, all the three isolated VRSA strains were also resistant to a wide range of different antimicrobial agents. Resistance to both rifampicin and fusidic acid was 66.7% in each antibiotic. All (100%) were resistant to erythromycin. But these were sensitive (66.7%) to linezolid, gentamycin and doxycycline. In the present study one VRSA isolate which was also resistant to linezolid was found in a patient aged 70 years, suffering from multiple co-morbidities with history of previous hospitalization. Eleven cases were full-blown infection; including five ventilator associated pneumonia, five bacteremia and one was catheter related sepsis.
Conclusion
In conclusion a significant number of VRSA has been found in the admitted patients in a tertiary care hospital in Bangladesh. This study also showed that VRSA colonized patients had history of previous hospitalization and were associated with multiple co-morbidities. In this study all VRSA strains were resistant to wide range of different antimicrobial agents. Although this study was confined within one tertiary care hospital in Bangladesh, the emergence of VRSA/VISA might also be prevalent in other hospitals as antibiotic misuse is equally common there. Hence, there should be an immediate response from the concerned authorities to check further emergence and spreading of these notorious VRSA strains. A strict regulation on irrational antibiotic usages might be an appropriate and effective approach in this direction. Moreover, nationwide surveillance program should be carried out to map the vancomycin susceptibility pattern in this country.
